State Street’s Ortho Clinical Diagnostics Holdings OCDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-2,648,579
Closed -$49.4M – 5018
2022
Q1
$49.4M Sell
2,648,579
-54
-0% -$972 ﹤0.01% 1773
2021
Q4
$56.7M Buy
2,648,633
+248,056
+10% +$4.89M ﹤0.01% 1723
2021
Q3
$44.4M Buy
2,400,577
+293,821
+14% +$5.92M ﹤0.01% 1892
2021
Q2
$45.1M Buy
2,106,756
+856,287
+68% +$17.4M ﹤0.01% 1922
2021
Q1
$24.1M Buy
+1,250,469
New +$22M ﹤0.01% 2247

Other funds holding OCDX

State Street's OCDX Position: Q2 2022 in Review

State Street sold out of Ortho Clinical Diagnostics Holdings (OCDX) in Q2 2022, closing a stake of 2,648,579 shares — an estimated $49.4M sold.

State Street first reported a position in OCDX in Q1 2021 and held it in 5 quarters. The position peaked at $56.7M in Q4 2021. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

  • State Street reported no remaining Ortho Clinical Diagnostics Holdings position as of Q2 2022 after selling out during the quarter.
  • State Street sold 2,648,579 Ortho Clinical Diagnostics Holdings shares in Q2 2022, an estimated $49.4M.
  • State Street first reported a position in Ortho Clinical Diagnostics Holdings in Q1 2021 and held it in 5 quarters.
  • State Street's Ortho Clinical Diagnostics Holdings position peaked at $56.7M in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings as of Q2 2022.

Based on State Street's 13F filing for Q2 2022, filed 15 Aug 2022.